Internal Medicine, Cardiovascular Disease · Cleveland, OH
NPI
1710059555
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (800) 223-2273
Medicare paid, 2024
$117K
1,727 services
Medicare patients, 2024
296
Average age 76
Drug cost, 2024
$1.1M
4,192 prescriptions
Company payments, 2025
$17.49
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashoka Nautiyal was code 99214 (office e&m - established), 527 times for 235 patients. In total Ashoka Nautiyal billed 1,727 services in 48 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 527 | 235 | $87.01 | $46K |
| 93000 Electrocardiogram | Office | 377 | 228 | $9.81 | $3,698 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 139 | 115 | $12.57 | $1,747 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 67 | 66 | $135.15 | $9,055 |
| 93306 Echocardiography (TTE/TEE) | Office | 66 | 60 | $132.83 | $8,766 |
| 99232 Hospital E&M - Subsequent | Facility | 57 | 24 | $59.54 | $3,394 |
| 93306 Echocardiography (TTE/TEE) | Facility | 53 | 48 | $50.85 | $2,695 |
| 93228 Electrocardiogram | Office | 52 | 31 | $18.71 | $973 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 45 | 12 | $8.42 | $379 |
| 93351 Echocardiography (TTE/TEE) | Office | 37 | 35 | $160.62 | $5,943 |
| 99204 Office E&M - New | Office | 31 | 31 | $105.52 | $3,271 |
| 99222 Hospital E&M - Initial | Facility | 27 | 22 | $94.74 | $2,558 |
| 78452 Myocardial Perfusion Scan | Office | 25 | 25 | $294.74 | $7,369 |
| 93015 Electrocardiogram | Office | 25 | 25 | $46.79 | $1,170 |
| 93246 Electrocardiogram | Office | 19 | 17 | $8.63 | $164 |
By year: 2022 $191K for 1,940 services; 2023 $123K for 1,554 services; 2024 $117K for 1,727 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashoka Nautiyal prescribed most often to Medicare patients was Atorvastatin Calcium, with 371 prescriptions and refills. In total Ashoka Nautiyal wrote 4,192 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 371 | 1,044 | 112 | $4,157 |
| Metoprolol Succinate Generic | 328 | 885 | 100 | $4,605 |
| Eliquis Apixaban | 307 | 544 | 70 | $309K |
| Repatha Sureclick Evolocumab | 180 | 229 | 24 | $126K |
| Lisinopril Generic | 177 | 480 | 52 | $1,035 |
| Furosemide Generic | 146 | 360 | 48 | $480 |
| Jardiance Empagliflozin | 141 | 262 | 33 | $150K |
| Spironolactone Generic | 140 | 372 | 40 | $1,119 |
| Metoprolol Tartrate Generic | 119 | 302 | 34 | $594 |
| Losartan Potassium Generic | 113 | 320 | 35 | $1,373 |
| Verquvo Vericiguat | 112 | 161 | 20 | $109K |
| Bisoprolol Fumarate Generic | 112 | 285 | 28 | $2,990 |
| Amlodipine Besylate Generic | 110 | 296 | 32 | $761 |
| Carvedilol Generic | 109 | 293 | 29 | $1,183 |
| Xarelto Rivaroxaban | 107 | 244 | 27 | $129K |
Brand drugs: - claims; generic drugs: 3,085 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashoka Nautiyal $17.49 ($17.49 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $17.49.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $17.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.